FMNB vs PRAA

FMNB presents a strong value opportunity, trading significantly below its Graham Number ($20.51) and Intrinsic Value ($17.55). The company maintains a stable financial health profile with a Piotroski F-Score of 4/9 and a healthy ROE of 12.24%, which vastly outperforms the sector average. While earnings growth is modest and recent quarterly surprises have been negative, the low P/E ratio and sustainable 4.88% dividend yield provide a significant margin of safety. The bullish outlook is driven by deep valuation discounts despite a bearish technical trend indicator.

PRAA presents a stark contrast between deep value metrics and severe fundamental deterioration, highlighted by a critical Piotroski F-Score of 1/9. While the stock trades at a discount to book value (P/B 0.83) and shows strong recent price momentum (+55.9% in 6 months), the underlying financial health is weak with a high Debt/Equity ratio of 3.60. The company is experiencing extreme earnings volatility, evidenced by a massive -2893.8% surprise in late 2025, though recent quarterly growth suggests a potential turnaround. Overall, the valuation is attractive, but the deterministic health scores signal high risk.